Targeting of nuclear Factor-κB and proteasome by dithiocarbamate complexes with metals

被引:121
|
作者
Cvek, B. [1 ]
Dvorak, Z. [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic
关键词
disulfiram; diethyldithiocarbamate (DDTC); pyrrolidinedithiocarbamate (PDTC); metal dithiocarbamates; NF-kappa B; proteasome; JAMM;
D O I
10.2174/138161207782110390
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dithiocarbamates and their complexes with transition metals have been used as common pesticides, vulcanizing or analytical agents for decades. These compounds are one of the most reported inhibitors of nuclear factor-kappa B (NF-kappa B) signaling cascade. Recently, it has been found that dithiocarbamates are very potent inhibitors of proteasome. NF-kappa B plays a central role in the immune system and is described as major actor in many of human cancers mainly because of its protective effects against apoptosis. Molecular mechanisms involved in regulation and function of NF-kappa B pathway have been elucidated recently. In particular, pivotal zinc containing proteins that alter NF-kappa B signal transduction were recognized, Additionally, proteasome system was found to be a key player in NF-kappa B pathway and is an attractive target for anticancer drug development Collectively, the capability of dithiocarbamates to inhibit NF-kappa B and proteasome makes these compounds promising anticancer agents. This review focuses on the biological activity of dithiocarbamate coordination compounds with regard to their possible molecular targets in NF-kappa B signaling and proteasome (JAMM domain proteins). Future research should aim to find the most suitable dithiocarbamate coordination compounds for treatment of cancer and other diseases.
引用
收藏
页码:3155 / 3167
页数:13
相关论文
共 50 条
  • [31] Inflammatory macrophage nuclear factor-κB and proteasome activity are inhibited following exposure to inhaled isobutyl nitrite
    Ponnappan, U
    Soderberg, LSF
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (04) : 639 - 644
  • [32] A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma
    Nishikawa, Sho
    Tanaka, Akane
    Matsuda, Akira
    Oida, Kumiko
    Jang, Hyosun
    Jung, Kyungsook
    Amagai, Yosuke
    Ahn, Ginae
    Okamoto, Noriko
    Ishizaka, Saori
    Matsuda, Hiroshi
    CANCER MEDICINE, 2014, 3 (02): : 416 - 425
  • [33] Targeting neddylation effectively antagonizes nuclear factor-κB in chronic lymphocytic leukemia B-cells
    Godbersen, J. Claire
    Paiva, Cody
    Danilova, Olga V.
    Berger, Allison
    Brown, Jennifer R.
    Danilov, Alexey V.
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1566 - 1569
  • [34] Expression of nuclear factor-κB and IκBα proteins in prostatic adenocarcinomas:: Correlation of nuclear factor-κB immunoreactivity with disease recurrence
    Ross, JS
    Kallakury, BVS
    Sheehan, CE
    Fisher, HAG
    Kaufman, RP
    Kaur, P
    Gray, K
    Stringer, B
    CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2466 - 2472
  • [35] Transforming growth factor-β induces the degradation of the hepatic nuclear factor-4 in the proteasome
    Bartolome, J
    De Lucas, S
    Carreno, V
    HEPATOLOGY, 2002, 36 (04) : 240A - 240A
  • [36] Nuclear factor-κB:: a transcription factor for all seasons
    Aggarwal, Bharat B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 109 - 110
  • [37] Nuclear targeting of transforming growth factor-b-activated smad complexes
    Chen, HB
    Rud, JG
    Lin, K
    Xu, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (22) : 21329 - 21336
  • [38] Chemoprotective Effect of a Nuclear Factor-κB Inhibitor, Pyrrolidine Dithiocarbamate, Against Cisplatin-Induced Testicular Damage in Rats
    Ilbey, Yusuf Ozlem
    Ozbek, Emin
    Simsek, Abdulmuttalip
    Cekmen, Mustafa
    Otunctemur, Alper
    Somay, Adnan
    JOURNAL OF ANDROLOGY, 2009, 30 (05): : 505 - 514
  • [39] Dithiocarbamate complexes with metals in cancer therapy
    Cvek, Boris
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (12) : 1173 - 1173
  • [40] Nuclear factor-κB activation in alveolar macrophages requires Iκkinase-β, but not nuclear factor-κB inducing kinase
    Conron, M
    Andreakos, E
    Pantelidis, P
    Smith, C
    Beynon, HLC
    Dubois, RM
    Foxwell, BMJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 996 - 1004